Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10768736 | Biochemical and Biophysical Research Communications | 2005 | 6 Pages |
Abstract
Functional activation of β-catenin/Tcf signaling plays an important role in early events in carcinogenesis. We examined the effect of naringenin against β-catenin/Tcf signaling in gastric cancer cells. Reporter gene assay showed that naringenin inhibited β-catenin/Tcf signaling efficiently. In addition, the inhibition of β-catenin/Tcf signaling by naringenin in HEK293 cells transiently transfected with constitutively mutant β-catenin gene, whose product is not phosphorylated by GSK3β, indicates that its inhibitory mechanism was related to β-catenin itself or downstream components. To investigate the precise inhibitory mechanism, we performed immunofluorescence, Western blot, and EMSA. As a result, our data revealed that the β-catenin distribution and the levels of nuclear β-catenin and Tcf-4 proteins were unchanged after naringenin treatment. Moreover, the binding activities of Tcf complexes to consensus DNA were not affected by naringenin. Taken together, these data suggest that naringenin inhibits β-catenin/Tcf signaling in gastric cancer with unknown mechanisms.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry
Authors
Ju Hyung Lee, Chi Hoon Park, Kyung Chae Jung, Ho Sung Rhee, Chul Hak Yang,